[
  {
    "cui": "C0398623",
    "cui_name": "Thrombophilia",
    "incidence_per_100k": null,
    "prevalence_per_100k": 5000,
    "metric_type": "prevalence",
    "total_cases_per_year": 400000000,
    "confidence": 0.65,
    "is_subtype": false,
    "parent_disease": null,
    "reasoning": "Thrombophilia prevalence estimated at ~5% (5,000 per 100k) globally based on combined frequency of major genetic variants (Factor V Leiden ~3-5%, Prothrombin G20210A ~2-3% in European populations, with lower prevalence in Asian and African populations). Reported as prevalence (lifelong predisposition) rather than incidence. Umbrella term encompassing inherited (Factor V Leiden, Prothrombin mutation, Antithrombin deficiency, Protein C/S deficiency) and acquired forms.",
    "data_quality": "moderate",
    "geographic_variation": "high",
    "year_specific": false,
    "data_year": null,
    "source": "Heit JA et al. (2016). Thrombophilia: clinical and molecular epidemiology. Am J Med Genet C Semin Med Genet. 175C(1):22-39",
    "source_url": "https://pubmed.ncbi.nlm.nih.gov/27649487/",
    "source_type": "literature"
  }
]
